3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Paclitaxel
77
pembrolizumab
59
Carboplatin
57
Bevacizumab
57
Specimen Handling
48
Magnetic Resonance Spectroscopy
39
Cisplatin
32
olaparib
31
Gemcitabine
25
liposomal doxorubicin
24
Biopsy
20
Taxes
19
Topotecan
17
Nivolumab
17
Cyclophosphamide
16
Immunoglobulin G
15
Doxorubicin
15
Disulfides
15
niraparib
12
fludarabine
12
Surveys and Questionnaires
12
Letrozole
12
lenvatinib
11
durvalumab
11
atezolizumab
11
Fulvestrant
10
Drug Therapy
10
abemaciclib
9
Docetaxel
9
Brachytherapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radionuclide Imaging
×
Gynecologic
×
90 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled